Bayer closes acquisition of consumer care business of Merck & Co., Inc. for USD 14.2 billion

06-Oct-2014 - Bayer has completed the acquisition of the consumer care business of the U.S. pharmaceuticals group Merck & Co., Inc., Whitehouse Station, New Jersey. The transaction closed on October 1, 2014, following receipt of required antitrust approvals. "This acquisition is a milestone for Bayer and we ...

Roche purchases shares in tender offer for InterMune, Inc.

01-Oct-2014 - Roche and InterMune, Inc. announced that Roche’s wholly owned subsidiary Klee Acquisition Corporation has accepted for payment all shares validly tendered pursuant to its tender offer for all outstanding shares of common stock of InterMune, Inc. at USD 74.00 per share in cash. The tender offer ...

Daiichi Sankyo to Acquire Ambit Biosciences

01-Oct-2014 - Daiichi Sankyo Company, Ltd. and Ambit Biosciences announced that they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences for $15 per share in cash through a tender offer followed by a merger with a ...

Bibby Scientific Ltd acquires PCRmax Ltd

29-Sep-2014 - Bibby Scientific has purchased 100% of the share capital of PCRmax, a UK based sales and distribution Company set up specifically to capture a significant market share of the standard (PCR) and quantitative PCR (QPCR) markets. They are also the registered owners of the intellectual property ...

Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

23-Sep-2014 - Merck and Sigma-Aldrich announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. Merck will acquire all of the outstanding ...

Janssen Affiliate Cilag GmbH International Acquires Covagen AG

27-Aug-2014 - Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology ...

Miltenyi Biotec acquires gene therapy assets from Lentigen Corporation

18-Aug-2014 - Miltenyi Biotec announced that it has acquired the lentiviral vector manufacturing business and related assets from US company Lentigen Corporation, a global leader in lentiviral technology for cell and gene therapy applications. The acquisition further strengthens Miltenyi Biotec’s portfolio in ...

Reprocell acquires Reinnervate and BioServe

07-Aug-2014 - Reinnervate Ltd has been acquired by Reprocell of Shin-Yokohama in Japan. Reprocell, a pioneer in the field of induced pluripotent stem cell biology supplies iPSC-dervided Hepatocytes, Neurons and Cardiomyocytes as well as a range of media and reagents for stem cell culture. Reprocell intends to ...

Roche to acquire Santaris Pharma

06-Aug-2014 - Roche announced that it has agreed to acquire Santaris Pharma. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics. This new class of medicines has the potential to address difficult to treat ...

Malvern Instruments completes acquisitions

Malvern Instruments completes acquisition of MicroCal and announces purchase of Archimedes product from Affinity Biosensors

04-Aug-2014 - Malvern Instruments Ltd has announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA). Both of these developments extend Malvern’s portfolio ...